(HUM) Humana (publ) - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0008040653

Elderly, Family, Mental, Residential, Assisted

HUM EPS (Earnings per Share)

EPS (Earnings per Share) of HUM over the last years for every Quarter: "2020-03": 1, "2020-06": 0.94, "2020-09": 2.05, "2020-12": 1.01, "2021-03": 1.27, "2021-06": 1.18, "2021-09": 2.56, "2021-12": 0.68, "2022-03": 0.6, "2022-06": 0.38, "2022-09": 2.17, "2022-12": 1.25, "2023-03": 1.07, "2023-06": 0.75, "2023-09": 1.71, "2023-12": 0.17, "2024-03": 0.44, "2024-06": 0.02, "2024-09": 1.81, "2024-12": 0.54, "2025-03": 1.44,

HUM Revenue

Revenue of HUM over the last years for every Quarter: 2020-03: 1932, 2020-06: 1980, 2020-09: 1929, 2020-12: 1947, 2021-03: 1984, 2021-06: 2058, 2021-09: 2033, 2021-12: 2112, 2022-03: 2147, 2022-06: 2241, 2022-09: 2373, 2022-12: 2442, 2023-03: 2467, 2023-06: 2457, 2023-09: 2408, 2023-12: 2396, 2024-03: 2407, 2024-06: 2535, 2024-09: 2666, 2024-12: 2687, 2025-03: 2533,

Description: HUM Humana (publ)

Humana AB (publ) is a leading provider of care services in the Nordic region, operating in Sweden, Finland, Norway, and Denmark. The companys comprehensive range of services includes individual and family care, elderly care, and specialized housing for individuals with functional impairments, mental illness, and substance abuse problems. With a strong presence in the region, Humana has established itself as a key player in the healthcare services sector.

From a business perspective, Humanas diversified service portfolio and geographic presence provide a stable foundation for growth. The companys focus on providing high-quality care services, combined with its ability to adapt to changing regulatory environments, positions it well for long-term success. Additionally, the Nordic regions emphasis on social welfare and healthcare services creates a favorable operating environment for Humana.

Analyzing the available data, we can observe that Humanas stock has experienced fluctuations in recent times. The current price of 36.50 SEK is below its 20-day and 50-day simple moving averages (SMA20: 36.79, SMA50: 38.91), indicating a potential downward trend. However, the stock is above its 200-day moving average (SMA200: 37.28), suggesting some underlying stability. The average true range (ATR) of 1.07, representing a 2.93% daily price movement, indicates moderate volatility.

Using the available technical and fundamental data, we can forecast Humanas stock performance. Given the current price-earnings ratio (P/E) of 12.63 and return on equity (RoE) of 6.31, we can expect a relatively stable performance in the short term. However, the stocks current price being below its 52-week high (46.37) and above its 52-week low (28.54) suggests potential for recovery. If the company can maintain its current growth trajectory and improve its profitability, we can expect the stock to appreciate in value, potentially reaching 40-42 SEK in the next 6-12 months, representing a 10-15% increase from current levels.

Additional Sources for HUM Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

HUM Stock Overview

Market Cap in USD 196m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception

HUM Stock Ratings

Growth Rating -16.9
Fundamental 32.6
Dividend Rating 17.6
Rel. Strength 20.7
Analysts -
Fair Price Momentum 33.23 SEK
Fair Price DCF 283.10 SEK

HUM Dividends

Dividend Yield 12m 2.75%
Yield on Cost 5y 2.08%
Annual Growth 5y %
Payout Consistency 25.6%
Payout Ratio 25.5%

HUM Growth Ratios

Growth Correlation 3m -60.8%
Growth Correlation 12m 72.9%
Growth Correlation 5y -70.2%
CAGR 5y -5.18%
CAGR/Max DD 5y -0.06
Sharpe Ratio 12m -0.13
Alpha 0.21
Beta 0.784
Volatility 34.34%
Current Volume 207.9k
Average Volume 20d 58.8k
Stop Loss 35.6 (-3.1%)
What is the price of HUM shares?
As of July 16, 2025, the stock is trading at SEK 36.75 with a total of 207,900 shares traded.
Over the past week, the price has changed by +1.36%, over one month by +1.36%, over three months by -15.00% and over the past year by +10.19%.
Is Humana (publ) a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Humana (publ) is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.57 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HUM is around 33.23 SEK . This means that HUM is currently overvalued and has a potential downside of -9.58%.
Is HUM a buy, sell or hold?
Humana (publ) has no consensus analysts rating.
What are the forecasts for HUM share price target?
According to our own proprietary Forecast Model, HUM Humana (publ) will be worth about 36.2 in July 2026. The stock is currently trading at 36.75. This means that the stock has a potential downside of -1.41%.
Issuer Target Up/Down from current
Wallstreet Target Price 48 30.6%
Analysts Target Price - -
ValueRay Target Price 36.2 -1.4%